Clinical Trials
23 trialsComprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy
Memorial Sloan Kettering Cancer Center
Abiraterone Acetate for Castrate Resistant Prostate Cancer
Massachusetts General Hospital
The Standard of Care Combined With Glucocorticoid in Elderly People With Mild or Moderate COVID-19
Huashan Hospital
R-CMOP in Patients With Primary Diffuse Large B-cell Lymphoma
The First Affiliated Hospital with Nanjing Medical University
A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL
First Affiliated Hospital Xi'an Jiaotong University
LAL1308
Gruppo Italiano Malattie EMatologiche dell'Adulto
Mixed Gel of Hydrocortisone and Aluminium Phosphate Preventing Endoscopic Submucosal Dissection Postoperative Stenosis for Patients With Large Esophageal Carcinoma
Peking University Third Hospital
Interfant06
Dutch Childhood Oncology Group
PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
Swiss Cancer Institute
Rituximab, Cyclophosphamide, Bortezomib, and Prednisone in Patients With Stage III/IV FL or MZL
University of Miami
The Study of Pegylated Liposomal Doxorubicin Contrast Epirubicin for the Treatment of Diffuse Large B-cell Lymphoma
Hebei Medical University Fourth Hospital
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
University of Miami
Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALL
Children's Oncology Group
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
St. Jude Children's Research Hospital
Randomized Study of Hormonal Regulation of Infantile Hemangioma
FDA Office of Orphan Products Development
Molecular Phenotype Changes and Personalized Treatment for CRPC
Tianjin Medical University Cancer Institute and Hospital
Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients
M.D. Anderson Cancer Center
Positron Emission Tomography Using Fludeoxyglucose F 18 in Predicting Response to Treatment in Patients Who Are Receiving Rituximab and Combination Chemotherapy for Newly Diagnosed Non-Hodgkin's Lymphoma
Case Comprehensive Cancer Center
LAMPP Trial for Peripheral and Cutaneous T-Cell Lymphoma
Rutgers, The State University of New Jersey
Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
Large Cell Lymphoma Pilot Study III
St. Jude Children's Research Hospital
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
St. Jude Children's Research Hospital